Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-kB-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation-Reference-Cited by-同舟云学术

Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-kB-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation

Published:1996-04 Issue:14 Volume:271 Page:7992-7998
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Galang Christina K.,García-Ramírez José J.,Solski Patricia A.,Westwick John K.,Der Channing J.,Neznanov Nickolay N.,Oshima Robert G.,Hauser Craig A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference65 articles.

1. The neu oncogene encodes an epidermal growth factor receptor-related protein

2. Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene

4. Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma

5. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer effect of zoledronic acid in endocrine-resistant breast cancer cells via HER-2 signaling;Biomedicine & Pharmacotherapy;2024-02

2. Chorionic villus-derived mesenchymal stem cell-mediated NRG1 upregulation promotes HTR-8/SVneo cells proliferation through the activation of the NF-κB signaling pathway;Heliyon;2023-08

3. Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers;PLOS ONE;2022-12-08

4. Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers;2021-08-18

5. Curcumin functions as a MEK inhibitor to induce a synthetic lethal effect on KRAS mutant colorectal cancer cells receiving targeted drug regorafenib;The Journal of Nutritional Biochemistry;2019-12